• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    France Neurology Devices Market

    ID: MRFR/HC/50064-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    France Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, CSF management, neurosurgery devices) and By End-user (hospitals & clinics, specialty center)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    France Neurology Devices Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    France Neurology Devices Market Summary

    The France Neurology Devices market is projected to experience substantial growth from 847.3 million USD in 2024 to 1872.5 million USD by 2035.

    Key Market Trends & Highlights

    France Neurology Devices Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate of 7.48 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1872.5 million USD, indicating robust expansion.
    • In 2024, the market is valued at 847.3 million USD, reflecting a solid foundation for future growth.
    • Growing adoption of advanced neurological technologies due to increasing prevalence of neurological disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 847.3 (USD Million)
    2035 Market Size 1872.5 (USD Million)
    CAGR (2025-2035) 7.48%

    Major Players

    Aesculap, Johnson & Johnson, Boston Scientific, NICO Corporation, Zynex Medical, Abbott Laboratories, Neurotech, Medtronic, Stimwave, Penumbra, Stryker, NeuroPace, Renishaw, Integra LifeSciences, Cadence Biomedical

    France Neurology Devices Market Trends

    The market for neurology devices in France is expanding significantly due to the rising incidence of neurological problems like epilepsy and Alzheimer's as well as an ageing population that is more vulnerable to these illnesses. Innovation in neurology devices is further fuelled by the French government's and healthcare authorities' backing of healthcare technology breakthroughs.

    In recent years, telemedicine and remote monitoring systems have gained popularity because they provide easy patient management and greater access to medical treatment, especially in France's rural areas. This change reflects patients' and healthcare providers' growing adoption of digital health solutions.

    The creation of customised neurology devices is also a result of the increased focus on precision medicine and individualised treatment plans. Businesses are taking advantage of this by incorporating machine learning and artificial intelligence into the creation of devices that have improved therapeutic and diagnostic capabilities.

    In line with patient preferences for comfort and use, recent trends show an increased emphasis on minimally invasive procedures and user-friendly interfaces. Collaborative research projects between French medical device makers and universities are another important market driver. These collaborations address certain local market demands and speed up the creation of novel products.

    Additionally, the French healthcare system is making investments to increase access to cutting-edge medical technologies, which will benefit makers of neurology devices. All things considered, these patterns show a vibrant and changing environment for the French market for neurology devices, suggesting a range of options for interested parties to consider.

    Market Segment Insights

    France Neurology Devices Market Segment Insights

    France Neurology Devices Market Segment Insights

    Neurology Devices Market Product Type Insights

    Neurology Devices Market Product Type Insights

    The France Neurology Devices Market displays a diverse range of product types that play a crucial role in addressing neurological disorders and brain-related health issues. Neurostimulation devices have gained significant traction within the market as they offer effective treatment options for conditions such as epilepsy, chronic pain, and depression.

    These devices, through electrical stimulation, can modulate neural activity, showcasing their importance in improving patient outcomes. Interventional neurology represents another vital segment, focusing on minimally invasive techniques to treat cerebrovascular diseases, which are prevalent in France due to an aging population and rising stroke rates.

    This technique significantly reduces recovery times and hospital stays, making it a preferred choice among healthcare providers. Cerebrospinal fluid (CSF) management devices are also essential in the treatment of conditions like hydrocephalus, where abnormal accumulation of CSF occurs.

    The growing awareness and advancements in such devices are propelling demand in hospitals and clinics across France, ultimately enhancing patient quality of life. On the other hand, neurosurgery devices facilitate critical surgical interventions in various neurological conditions, including brain tumors and spinal disorders.

    Neurology Devices Market

    Neurology Devices Market End-user Insights

    The End-user segment of the France Neurology Devices Market is characterized by a dynamic landscape, primarily driven by the needs of hospitals and clinics alongside specialty centers. Hospitals and clinics represent a substantial portion of the market, owing to their broad patient base requiring neurological care and diverse treatment options.

    These facilities are equipped with advanced neurology devices that enhance diagnosis and treatment efficacy in a range of neurological conditions. Specialty centers are gaining traction as they facilitate focused and specialized treatment protocols, addressing complex neurological disorders with tailored approaches.

    These centers often integrate cutting-edge technology and research capabilities, providing significant contributions to patient outcomes. The growing awareness and advancement in neurology devices among healthcare providers further amplify the France Neurology Devices Market, ensuring enhanced patient care through improved diagnostics and therapeutic targets.

    Get more detailed insights about France Neurology Devices Market Research Report- Forecast to 2035

    Key Players and Competitive Insights

    The France Neurology Devices Market is characterized by a highly competitive landscape, driven by advancements in technology and increasing healthcare demands. With a growing elderly population and a rising prevalence of neurological disorders, the market has seen a surge in the development and deployment of innovative neurology devices.

    Key players in this sector are continuously leveraging research and development to enhance the efficacy and safety of their products, enabling them to gain a significant foothold in the market. As competition intensifies, companies are focusing on strategic partnerships, mergers, and acquisitions to bolster their market presence and expand their product portfolios.

    This dynamic environment enables rapid advancements in neurology devices, positioning France as a crucial hub for innovation in neurological healthcare solutions. In the context of the France Neurology Devices Market, Aesculap emerges as a noteworthy player with a robust presence.

    The company is recognized for its commitment to quality and innovation in neurology devices, delivering a wide array of surgical instruments and implants tailored for neurosurgical applications. Aesculap's strengths lie in its strong research capabilities and rigorous quality assurance programs, which ensure that their products meet the highest industry standards.

    The company's history of collaboration with healthcare professionals to develop effective neurosurgical solutions enhances its credibility and market trust. Aesculap's focus on customer satisfaction and its dependency on feedback for product improvements contribute to its competitive advantage in France’s neurology device sector.

    Johnson & Johnson holds a significant position in the France Neurology Devices Market, bolstered by its diverse portfolio of healthcare products and services. The company offers a range of neurosurgical devices, including advanced neuromodulation technologies and innovative surgical instrumentations.

    This extensive product range reflects Johnson & Johnson's commitment to addressing various neurological conditions, reinforcing its market presence in France. The company's strengths also lie in its robust distribution network that enables timely delivery of products, as well as comprehensive customer support services that enhance user experience.

    Additionally, Johnson & Johnson has engaged in strategic mergers and acquisitions, further fortifying its foothold in the neurology sector. By acquiring innovative firms and integrating their technologies, Johnson & Johnson continually expands its capabilities and enhances its product offerings within France, ensuring their position as a leader in the neurology devices arena.

    Key Companies in the France Neurology Devices Market market include

    Industry Developments

    The France Neurology Devices Market has seen notable developments recently, particularly with significant growth in market valuation attributed to advances in technology and increasing investment in Research and Development among leading companies such as Medtronic, Boston Scientific, and Abbott Laboratories.

    In August 2023, Medtronic announced a partnership with Neurotech to enhance their neurostimulation portfolio, indicating a trend towards collaboration in innovation. Furthermore, in July 2023, Boston Scientific expanded its operations in France, aiming to increase the accessibility of its neurology products to healthcare providers.

    The last two to three years have reported considerable advancements, including the introduction of minimally invasive devices aimed at treating neurological disorders, with notable product launches in March 2022 by NeuroPace. Regarding mergers and acquisitions, the landscape has seen Aesculap acquire a smaller company focusing on neuromodulation devices in June 2023, enhancing its presence in the French market.

    The competitive dynamics in France are also evolving, with strong regulatory support for innovation in neurology equipment, encouraging companies to expand their offerings and improve patient outcomes.

    Market Segmentation

    Neurology Devices Market End-user Outlook

    • hospitals & clinics
    • specialty center

    Neurology Devices Market Product Type Outlook

    • neurostimulation
    • interventional neurology
    • CSF management
    • neurosurgery devices

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 785.81(USD Million)
    MARKET SIZE 2024 847.26(USD Million)
    MARKET SIZE 2035 1872.5(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.476% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Aesculap, Johnson & Johnson, Boston Scientific, NICO Corporation, Zynex Medical, Abbott Laboratories, Neurotech, Medtronic, Stimwave, Penumbra, Stryker, NeuroPace, Renishaw, Integra LifeSciences, Cadence Biomedical
    SEGMENTS COVERED Product Type, End User
    KEY MARKET OPPORTUNITIES Innovative neurostimulation therapies, AI-driven diagnostic tools, Wearable neurological monitoring devices, Telehealth integration for neurology, Advanced surgical robotics for neurology
    KEY MARKET DYNAMICS Increasing neurological disorders prevalence, Advancements in diagnostic technology, Growing demand for minimally invasive procedures, Government funding and support, Aging population and healthcare access
    COUNTRIES COVERED France

    FAQs

    What was the market size of the France Neurology Devices Market in 2024?

    The France Neurology Devices Market was valued at approximately 847.26 million USD in 2024.

    What is the projected market size for the France Neurology Devices Market by 2035?

    By 2035, the France Neurology Devices Market is expected to reach a valuation of around 1872.5 million USD.

    What is the expected CAGR for the France Neurology Devices Market from 2025 to 2035?

    The market is anticipated to grow at a compound annual growth rate of 7.476 percent between 2025 and 2035.

    Which product segment is the largest within the France Neurology Devices Market?

    The interventional neurology segment is projected to be the largest, valued at 550.0 million USD by 2035.

    What are the major segments contributing to the France Neurology Devices Market?

    Key segments include neurostimulation, interventional neurology, CSF management, and neurosurgery devices.

    Who are the major players in the France Neurology Devices Market?

    Key players include Aesculap, Johnson & Johnson, Boston Scientific, Medtronic, and Abbott Laboratories.

    What is the expected value of neurostimulation devices in the market by 2035?

    The neurostimulation devices segment is projected to be valued at 400.0 million USD by 2035.

    How much is the CSF management segment expected to grow by 2035?

    The CSF management segment is expected to reach a valuation of approximately 300.0 million USD by 2035.

    What challenges does the France Neurology Devices Market face?

    The market faces challenges such as regulatory hurdles and high costs of advanced neurology devices.

    What opportunities exist in the France Neurology Devices Market?

    The market offers opportunities in technological advancements and increasing rates of neurological disorders.

    France Neurology Devices Market Research Report- Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials